Brain metastases: epidemiology and pathophysiology

By I. Gavrilovic, J. Posner. Journal of Neuro-Oncology, 2005

882 citations recorded by the source corpus.

Subfields: Genetics, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/7b55675815873cdc3a306d40bdc9e7243a217b0f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. J. Massagué

In Oncology

1. J. Massagué
2. D. Nguyen
3. X. Zhang
4. W. Gerald
5. M. Kris
6. R. Weinberg
7. Y. Fouad
8. C. Aanei

In Pulmonary and Respiratory Medicine

1. J. Massagué
2. Marc Ladanyi
3. M. Kris
4. D. Nguyen
5. E. Hay

Citations in the corpus

• Serpins Promote Cancer Cell Survival and Vascular Cooption in Brain Metastasis (2014, neutral): “Brain relapse is the most devastating complication of cancer, with acute neurologic distress and high mortality being typical traits (Gavrilovic and Posner, 2005).”
• WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis (2009, background): “Brain metastasis has particularly morbid physical and cognitive consequences (Gaspar, 2004; Gavrilovic and Posner, 2005; Thomas et al., 2000).”
• Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) (2017, background): “Although there are no global or national population-based estimates on the true incidence of brainmetastases, conservative estimates are that 10% to 30% of patients with lung cancer will develop brain metastases.(3) In the past, survival after the development of brain metastaseswas poor and treatmen”